If you have Type II Diabetes, talk to your GP about the possible use of a GLP1RA to supplement Metformin. Recent studies confirm the effectiveness of GLP1RAs such as Semaglutide in glucose reduction and assistance in weight control. They also appear to have positive effects on other systems including renal and cardiac function, and restoration of NK cell functionality leading to possible reduction in the incidence of cancer. These combined effects suggest a significant increase in lifespan is possible.

This was the view a year ago:


Ozempic (Semaglutide) weekly injection

More recent research confirms this and notes additional benefits: